8,517 articles
Matteo Adinolfí
Matteo Adinolfí (1928–2020) was an immunologist known for alpha-fetoprotein research that underpinned antenatal screening for neural tube defects and for detecting fetal cells in maternal blood.
Matteo Iannacone
Matteo Iannacone is an Italian immunologist and physician-scientist who leads immunology research at the San Raffaele Scientific Institute in Milan, focused on liver immune responses and hepatitis B.
Matthæus Ratzeberger
Matthæus Ratzeberger (also spelled Ratzenberger), 1501 to 1559, was a German physician who treated Martin Luther and served as personal physician to Elector Johann Friedrich I of Saxony.
Matthew Berriman
Matthew Berriman, known as Matt Berriman, is a parasite genomics researcher who led the parasite genomics group at the Wellcome Sanger Institute and is now Professor of Parasitology at Glasgow.
Matthew Biggerstaff
Matthew Biggerstaff is an American infectious disease epidemiologist at the CDC who leads the Influenza Division's modeling team and helped build US epidemic forecasting systems.
Matthew C. Kiernan
Matthew C. Kiernan, also known as Matthew Kiernan, is an Australian neurologist and CEO of Neuroscience Research Australia, known for ALS research and the Sheila Essey Award.
Matthew D. Breyer
Matthew D. Breyer is an American nephrologist who was a Vanderbilt professor of medicine for 21 years, then led diabetic kidney disease drug discovery at Eli Lilly and Janssen.
Matthew D. Galsky
Matthew D. Galsky is an American medical oncologist at Mount Sinai specializing in bladder and other genitourinary cancers, leading phase 3 immunotherapy trials in urothelial carcinoma.
Matthew D. Hellmann
Matthew D. Hellmann is a medical oncologist and drug developer, formerly of Memorial Sloan Kettering, known as lead author of the CheckMate 227 lung cancer immunotherapy trial reports.
Matthew D. Hirschey
Matthew D. Hirschey is an American metabolism researcher and Associate Professor at the Duke Molecular Physiology Institute, known for his 2010 Nature paper on the sirtuin SIRT3.
Matthew D. McHugh
Matthew D. McHugh is an American nurse scientist at the University of Pennsylvania who directs CHOPR and was elected to the National Academy of Medicine in 2020.
Matthew D. Scharff
Matthew D. Scharff is an American immunologist and cell biologist at Albert Einstein College of Medicine, elected to the National Academy of Sciences in 1982, known for work on somatic mutation and antibody diversity.
Matthew G. Vander Heiden
Matthew G. Vander Heiden is an American physician-scientist at MIT who studies cancer metabolism, directs the Koch Institute, and was elected to the National Academy of Medicine in 2024.
Matthew H. Spitzer
Matthew H. Spitzer is an immunologist and associate professor at UCSF, known for a 2017 Cell paper showing cancer immunotherapy requires immune activation beyond the tumor.
Matthew Hotopf
Matthew Hotopf is a British psychiatric epidemiologist and consultant liaison psychiatrist at King's College London, known for Lancet studies on chronic fatigue syndrome and Iraq veterans.
Matthew J. Ellis
Matthew J. Ellis is a breast cancer oncologist and cancer genomics researcher who directed the Lester and Sue Smith Breast Center at Baylor and joined AstraZeneca in 2022.
Matthew J. Farrer
Matthew J. Farrer, also published as Matthew Farrer, is a Canadian-based neurogeneticist known for discovering SNCA gene multiplications and LRRK2 mutations as genetic causes of Parkinson's disease.
Matthew J. Miller
Matthew J. Miller, also known as Matthew Jason Miller, is an American epidemiologist and physician at Northeastern University whose research links household firearm access to suicide risk.
Matthew J. Walter
Matthew J. Walter is an American hematologist-oncologist at Washington University School of Medicine in St. Louis whose genome sequencing research tracks how myelodysplastic syndromes progress to acute myeloid leukemia.
Matthew L. Albert
Matthew L. Albert is an American immunologist and physician-scientist known for work on cross-presentation, how dendritic cells acquire antigen from dying cells and stimulate CD8+ T cells.
Matthew L. Freedman
Matthew L. Freedman is a physician-scientist in cancer genomics, Professor of Medicine at Harvard Medical School and holder of the David Goldstein Chair at Dana-Farber Cancer Institute.
Matthew M. Rechler
Matthew M. Rechler is an NIH researcher in endocrinology and diabetes known for defining the receptors and carrier proteins of the insulin-like growth factors, once called somatomedins.
Matthew Maenner
Matthew Maenner is a CDC epidemiologist who studies autism spectrum disorder, helped develop a faster ADDM prevalence method, and estimated about 5.4 million US adults with autism.
Matthew P. Frosch
Matthew P. Frosch is an American neuropathologist who directs the C.S. Kubik Laboratory at Massachusetts General Hospital and studies Alzheimer's disease and cerebral amyloid angiopathy.
Matthew R. Smith
Matthew R. Smith, also published as Matthew Raymond Smith, is an American medical oncologist specializing in prostate cancer who directs the Genitourinary Malignancies Program at Mass General Cancer Center.
Matthew R. Sydes
Matthew R. Sydes is a British medical statistician and clinical-trials methodologist, known for the STAMPEDE prostate cancer platform trial and multi-arm multi-stage designs, now Head of Data-Driven Clinical Trials at NHS England.
Matthew S. Broadhurst
Matthew S. Broadhurst is an Australian ear, nose, and throat surgeon in Brisbane whose research centers on angiolytic laser surgery of the larynx, developed at Harvard.
Matthew W Johnson
Matthew W Johnson is an American behavioral pharmacologist at Johns Hopkins known for psilocybin trials in tobacco addiction and cancer distress, and 2008 psychedelic safety guidelines.
Matthew W. Semler
Matthew W. Semler is a critical care physician and clinical researcher at Vanderbilt University Medical Center who co-founded the Pragmatic Critical Care Research Group and leads large randomized trials of fluids, intubation, and oxygen targets.
Matthias Egger
Matthias Egger is a Swiss epidemiologist and public health physician at the University of Bern, known for the 1997 BMJ test for bias in meta-analysis.